Foghorn Therapeutics (FHTX) has received a new Buy rating, initiated by B.Riley Financial analyst, Kalpit Patel. Kalpit Patel’s rating is based on Foghorn Therapeutics’ innovative approach to ...

B. Riley initiated coverage of Foghorn Therapeutics (FHTX) with a Buy rating and $10 price target. The firm says its investment thesis centers on the company’s strategy to inactivate or degrade ...

A flight leaving Sumburgh for Glasgow early this afternoon made an emergency diversion to Aberdeen after a a passenger became ill. The flight took off from Shetland around 12.30pm and was due to ...

In 2017, Audible released a pair of immersive audio dramas of The X-Files, with David Duchovny as Mulder and Gillian Anderson as Scully, that fit “somewhere between season 10 and 11” of the TV series.

CAMBRIDGE, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Foghorn ® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious ...